Home LiteratureArticle Details
PMID: 11076965 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

c-Jun activation-dependent tumorigenic transformation induced paradoxically by overexpression or block of S-adenosylmethionine decarboxylase.

The Journal of cell biology ·Vol. 151 ·No. 4 ·2000-11-13 ·Pages 801-10

Paasinen-Sohns A, Kielosto M, Kääriäinen E, Eloranta T, Laine A, Jänne OA, Birrer MJ, Hölttä E

Abstract

All mammalian cells absolutely require polyamines (putrescine, spermidine, and spermine) for growth. Here we show that the overexpression of cDNA for S-adenosylmethionine decarboxylase (AdoMetDC), the main regulatory enzyme in the biosynthesis of higher polyamines, induces transformation of rodent fibroblasts when expressed in the sense or the antisense orientation. Both transformants were able to induce invasive tumors in nude mice. Neither transformation was associated with activation of the mitogen-activated protein kinases Erk1 and Erk2. Instead, the AdoMet DC sense, but not antisense, transformants displayed constitutive activation of the c-Jun NH(2)-terminal kinase (JNK) pathway. However, both transformations converged on persistent phosphorylation of endogenous c-Jun at Ser73. The phenotype of the AdoMetDC sense transformants was reversed by expression of dominant-negative mutants of SEK1 (MKK4), JNK1, and c-Jun (TAM-67), which were also found to impair cytokinesis. Similarly, TAM-67 reverted the morphology of the AdoMetDC-antisense expressors. This report is the first demonstration of a protein whose overexpression or block of synthesis can induce cell transformation. In addition, we show that the polyamine biosynthetic enzymes require c-Jun activation for eliciting their biological effects.

MeSH Terms
3T3 Cells Adenosylmethionine Decarboxylase/genetics,metabolism Animals Cell Transformation, Neoplastic DNA, Antisense Enzyme Activation Humans JNK Mitogen-Activated Protein Kinases MAP Kinase Kinase 4 Mice Mice, Nude Mitogen-Activated Protein Kinase 1/metabolism Mitogen-Activated Protein Kinase 3 Mitogen-Activated Protein Kinase Kinases/metabolism Mitogen-Activated Protein Kinases/metabolism Ornithine Decarboxylase/metabolism Phosphorylation Phosphoserine/metabolism Recombinant Proteins/metabolism Transfection
Chemicals
DNA, Antisense Recombinant Proteins Phosphoserine JNK Mitogen-Activated Protein Kinases Mitogen-Activated Protein Kinase 1 Mitogen-Activated Protein Kinase 3 Mitogen-Activated Protein Kinases MAP Kinase Kinase 4 MAP2K4 protein, human Map2k4 protein, mouse Mitogen-Activated Protein Kinase Kinases Ornithine Decarboxylase Adenosylmethionine Decarboxylase
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Paasinen-Sohns A
Haartman Institute, Department of Pathology, FIN-00014 University of Helsinki, Helsinki, Finland.
Kielosto M
Kääriäinen E
Eloranta T
Laine A
Jänne O A
Birrer M J
Hölttä E
References (55)
55 references, click to expand
  1. The MAPK signaling cascade.
    FASEB J. 1995 Jun;9(9):726-35 PMID: 7601337
  2. Role of ornithine decarboxylase in epidermal tumorigenesis.
    Cancer Res. 1995 Apr 15;55(8):1680-6 PMID: 7712475
  3. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation.
    Mol Cell Biol. 1995 Nov;15(11):6443-53 PMID: 7565796
  4. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.
    Science. 1995 Nov 24;270(5240):1326-31 PMID: 7481820
  5. The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation.
    Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11746-50 PMID: 8524841
  6. MAPK activity is down-regulated in human colon adenocarcinoma: correlation with PKC activity.
    Anticancer Res. 1996 Jan-Feb;16(1):395-9 PMID: 8615643
  7. Delay in serum stimulation of Erk activity caused by oncogenic transformation.
    Oncogene. 1996 Apr 18;12(8):1689-95 PMID: 8622889
  8. Cellular transformation and malignancy induced by ras require c-jun.
    Mol Cell Biol. 1996 Aug;16(8):4504-11 PMID: 8754851
  9. How cancer arises.
    Sci Am. 1996 Sep;275(3):62-70 PMID: 8701295
  10. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
    Oncogene. 1996 Aug 1;13(3):455-60 PMID: 8760286
  11. Mitogen-activated protein kinase cascades and regulation of gene expression.
    Curr Opin Immunol. 1996 Jun;8(3):402-11 PMID: 8793994
  12. Mek1 phosphorylation site mutants activate Raf-1 in NIH 3T3 cells.
    J Biol Chem. 1996 Dec 6;271(49):31612-8 PMID: 8940180
  13. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions.
    Cell. 1996 Nov 29;87(5):929-39 PMID: 8945519
  14. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation.
    J Biol Chem. 1996 Dec 13;271(50):31929-36 PMID: 8943238
  15. Activation of extracellular signal-regulated kinase (ERK) by mitogenic stimuli is repressed in v-Src-transformed cells.
    Cell Growth Differ. 1997 Jan;8(1):113-9 PMID: 8993840
  16. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases.
    Science. 1997 Jan 17;275(5298):400-2 PMID: 8994040
  17. p120 GAP modulates Ras activation of Jun kinases and transformation.
    J Biol Chem. 1997 Jan 17;272(3):1677-81 PMID: 8999845
  18. AP-1 function and regulation.
    Curr Opin Cell Biol. 1997 Apr;9(2):240-6 PMID: 9069263
  19. Downstream of Crk adaptor signaling pathway: activation of Jun kinase by v-Crk through the guanine nucleotide exchange protein C3G.
    Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2356-61 PMID: 9122199
  20. Transcriptional activation and transformation by FosB protein require phosphorylation of the carboxyl-terminal activation domain.
    Mol Cell Biol. 1997 May;17(5):2372-80 PMID: 9111306
  21. Activation of the JNK pathway is essential for transformation by the Met oncogene.
    EMBO J. 1997 May 15;16(10):2634-45 PMID: 9184210
  22. Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin.
    Cancer Res. 1997 Jul 1;57(13):2630-7 PMID: 9205069
  23. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice.
    Cancer Res. 1997 Jul 15;57(14):3016-25 PMID: 9230217
  24. Cells transformed by ODC, c-Ha-ras and v-src exhibit MAP kinase/Erk-independent constitutive phosphorylation of Sos, Raf and c-Jun activation domain, and reduced PDGF receptor expression.
    Oncogene. 1997 Oct 16;15(16):1953-66 PMID: 9365242
  25. Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development.
    Curr Opin Cell Biol. 1998 Apr;10(2):205-19 PMID: 9561845
  26. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
    Clin Cancer Res. 1999 May;5(5):945-51 PMID: 10353725
  27. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion.
    Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9827-32 PMID: 10449779
  28. Polyamines in mammalian tumors. Part II.
    Adv Cancer Res. 1982;36:1-102 PMID: 6289636
  29. Polyamines.
    Annu Rev Biochem. 1984;53:749-90 PMID: 6206782
  30. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor.
    Cell. 1987 Jun 19;49(6):729-39 PMID: 3034432
  31. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy.
    Cancer Res. 1988 Feb 15;48(4):759-74 PMID: 3123052
  32. Structure and regulation of mammalian S-adenosylmethionine decarboxylase.
    J Biol Chem. 1988 Nov 15;263(32):17040-9 PMID: 2460457
  33. Molecular genetics of polyamine synthesis in eukaryotic cells.
    Trends Biochem Sci. 1990 Apr;15(4):153-8 PMID: 2187296
  34. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.
    Nucleic Acids Res. 1990 Jun 25;18(12):3587-96 PMID: 2194165
  35. Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain.
    Nature. 1991 May 9;351(6322):122-7 PMID: 1903181
  36. The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells.
    Mol Cell Biol. 1991 Dec;11(12):6286-95 PMID: 1944289
  37. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73.
    Nature. 1991 Dec 12;354(6353):494-6 PMID: 1749429
  38. Monitoring of the uptake and metabolism of aminooxy analogues of polyamines in cultured cells by high-performance liquid chromatography.
    J Chromatogr. 1992 Feb 7;574(1):17-21 PMID: 1629283
  39. Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73.
    Mol Cell Biol. 1992 Aug;12(8):3507-13 PMID: 1630458
  40. Activation of the MAP kinase pathway by the protein kinase raf.
    Cell. 1992 Oct 16;71(2):335-42 PMID: 1330321
  41. Ornithine decarboxylase activity is critical for cell transformation.
    Nature. 1992 Nov 26;360(6402):355-8 PMID: 1280331
  42. Suppression of oncogene-induced transformation by a deletion mutant of c-jun.
    Oncogene. 1993 Apr;8(4):877-86 PMID: 8455942
  43. S-adenosylmethionine decarboxylase as an enzyme target for therapy.
    Pharmacol Ther. 1992 Dec;56(3):359-77 PMID: 1301596
  44. The ornithine decarboxylase gene is a transcriptional target of c-Myc.
    Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7804-8 PMID: 8356088
  45. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase.
    Mol Cell Biol. 1993 Oct;13(10):6241-52 PMID: 8413224
  46. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.
    Genes Dev. 1993 Nov;7(11):2135-48 PMID: 8224842
  47. Mechanism of action of a dominant-negative mutant of c-Jun.
    Oncogene. 1994 Mar;9(3):791-9 PMID: 8108121
  48. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.
    Cell. 1994 Mar 25;76(6):1025-37 PMID: 8137421
  49. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
    Cancer Res. 1994 Jun 15;54(12):3210-7 PMID: 8205541
  50. Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular signal-regulated kinases.
    Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6030-4 PMID: 8016110
  51. Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant.
    Oncogene. 1994 Dec;9(12):3493-8 PMID: 7970709
  52. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1.
    Nature. 1994 Dec 22-29;372(6508):798-800 PMID: 7997270
  53. MAPKs: new JNK expands the group.
    Trends Biochem Sci. 1994 Nov;19(11):470-3 PMID: 7855889
  54. MAP kinase activation is essential for oncogenic transformation of NIH3T3 cells by Mos.
    Oncogene. 1995 Mar 16;10(6):1149-57 PMID: 7700641
  55. Treatment of nude mice with 4-amidinoindan -1- one2 '- amidinohydrazone, a new S-adenosylmethionine decarboxylase inhibitor, delays growth and inhibits metastasis of human melanoma cells.
    Melanoma Res. 1995 Jun;5(3):147-54 PMID: 7640515
Article Info
Journal
The Journal of cell biology
Abbr.
J Cell Biol
ISSN
0021-9525
Published
2000-11-13
Pages
801-10
Language
English
Region
United States
NLM ID
0375356
PMCID
PMC2169445
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]